[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Dyne Therapeutics, Inc. Common Stock](/topic/dyne-therapeutics)

### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% +31%  
**6 Months**: XXX% +40%  
**1 Year**: XXX% +42%  
**1-Year High**: XXX% on 2025-10-18  
**1-Year Low**: XX% on 2025-01-04  

**Most Supportive Themes**
- **Positive Clinical Data and Breakthrough Designations:** (45%) Dyne Therapeutics' positive one-year clinical data from the ACHIEVE trial for DM1 and breakthrough designations are driving positive sentiment.
- **Analyst Ratings and Price Targets:** (25%) Favorable analyst ratings and price targets, with a consensus of Strong Buy and a potential upside, are supporting the stock.
- **Strong Institutional Confidence:** (15%) High institutional ownership and confidence from major funds are contributing to the positive outlook.
  
**Most Critical Themes**
- **Downgrades and Valuation Concerns:** (15%)  Downgrades from some analysts and concerns about valuation, despite promising clinical data, are creating some caution.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %   | Negative | %  |
| ------- | -------- | -  | ------- | -   | -------- | -  |
| X       | XXX      | X% | XXXXX   | XX% | X        | X% |
| News    | X        | X% | X       | X%  | X        | X% |
| TikTok  | X        | X% | X       | X%  | X        | X% |
|         |          |    |         |     |          |    |
| Total   | XXX      | X% | XXXXX   | XX% | X        | X% |